Correlation Between SynCore Biotechnology and EirGenix

Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and EirGenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and EirGenix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SynCore Biotechnology Co and EirGenix, you can compare the effects of market volatilities on SynCore Biotechnology and EirGenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of EirGenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and EirGenix.

Diversification Opportunities for SynCore Biotechnology and EirGenix

0.18

Correlation Coefficient

SynCore Biotechnology  EirGenix

Average diversification

The 3 months correlation between SynCore and EirGenix is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and EirGenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EirGenix and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with EirGenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EirGenix has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and EirGenix go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and EirGenix

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the EirGenix. In addition to that, SynCore Biotechnology is 1.86 times more volatile than EirGenix. It trades about -0.01 of its total potential returns per unit of risk. EirGenix is currently generating about 0.09 per unit of volatility. If you would invest  7,110  in EirGenix on December 25, 2024 and sell it today you would earn a total of  560.00  from holding EirGenix or generate 7.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

SynCore Biotechnology Co  vs.  EirGenix

SynCore Biotechnology

Risk-Adjusted Performance

Very Weak

Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, SynCore Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

EirGenix

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in EirGenix are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, EirGenix may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with SynCore Biotechnology and EirGenix

The main advantage of trading using opposite SynCore Biotechnology and EirGenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, EirGenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EirGenix will offset losses from the drop in EirGenix's long position.

The idea behind SynCore Biotechnology Co and EirGenix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.